October 5, 2026Stocks·Neutral·m&a
Standard BioTools sells microfluidics business to ARCHIMED; amount not disclosed
Standard BioTools has sold its microfluidics business to ARCHIMED, according to a report. The transaction amount was not disclosed.
Detected & updated continuously · Source: Nebula
Story subjects
Standard BioTools Inc.ARCHIMED